PMID: 9194248Jun 1, 1997Paper

Long-term benzodiazepine use: factors of importance and the development of individual use patterns over time--a 13-year follow-up in a Swedish community

Social Science & Medicine
D Isacson

Abstract

Using data from a research registry of prescriptions, we studied benzodiazepine use in a Swedish community with a general population of 20,000. A sample of benzodiazepine users in 1976 (n = 561) aged 15 years and older was identified and followed for 13 years with respect to continued benzodiazepine use. A strong tendency towards continued use was observed. A majority of the cohort, 65%, continued benzodiazepine use during the first follow-up year, and 55% used benzodiazepines during the second. One-quarter of the sample continued using benzodiazepines during all years of the 13-year follow-up. One of the aims was to analyze factors predicting long-term benzodiazepine use. The multivariate analyses, using Cox regression analysis, showed that frequent/daily use and age were important factors. Gender and type of generic benzodiazepine were of little importance. Further, patients who were prescribed benzodiazepines by doctors working at hospitals and those who obtained prescriptions from both primary and hospital care physicians continued to use benzodiazepines to a greater extent than those patients who obtained prescriptions only from private practitioners or health center doctors. Another aim was to analyze to what extent long-...Continue Reading

References

Oct 1, 1992·Journal of Clinical Psychopharmacology·M K RomachE M Sellers
Apr 1, 1992·Journal of Clinical Epidemiology·D IsacsonJ L Blackburn
Feb 1, 1992·Journal of Clinical Epidemiology·A MorabiaJ P Dunand
Jan 1, 1989·Clinical Pharmacokinetics·U BustoE M Sellers
Jan 23, 1988·British Medical Journal·A MantA H Chancellor
Jan 1, 1987·Psychopharmacology·H CappellM Sanchez-Craig
Nov 1, 1988·Medical Care·D Isacson, B Smedby
May 1, 1988·Scandinavian Journal of Primary Health Care·R Westerling
Sep 1, 1985·Journal of Health and Social Behavior·L M Verbrugge
Sep 1, 1971·Journal of Health and Social Behavior·R Cooperstock
Jan 1, 1984·Current Medical Research and Opinion·M B BalterE H Uhlenhuth
Jun 1, 1983·Journal of Health and Social Behavior·G L CafferataA Bernstein
Jan 1, 1982·Social Science & Medicine·R S HadsallG J Norwood
Feb 1, 1994·American Journal of Public Health·G BlennowG Karlsson
Feb 1, 1993·Social Science & Medicine·D IsacsonM Dahlström

❮ Previous
Next ❯

Citations

May 17, 2005·European Journal of Clinical Pharmacology·Rutger StuffkenAntoine C G Egberts
Feb 8, 2011·European Journal of Clinical Pharmacology·Maria RikalaSirpa Hartikainen
Sep 20, 2011·European Journal of Clinical Pharmacology·Svein R KjosavikSteinar Hunskaar
Jul 22, 1999·Social Science & Medicine·P BendtsenA K Stridsman
Jul 18, 2012·Canadian Journal on Aging = La Revue Canadienne Du Vieillissement·Michel PrévilleYola Moride
Apr 24, 1999·Psychiatry and Clinical Neurosciences·J IshigookaM Murasaki
Aug 8, 2009·Journal of Community Health Nursing·Philippe VoyerSarah-Gabrielle Beland
Apr 7, 2007·European Journal of Public Health·Thijs FassaertC Joris Yzermans
Jan 5, 2011·Family Practice·N A H de GierF Zitman
Mar 22, 2013·Family Practice·Inge A T WillemsPeter L B J Lucassen
May 23, 2002·Journal of Clinical Pharmacology·Mitchell Levine, Jarold Cosby
Oct 26, 2005·Journal of Community Health Nursing·Philippe VoyerMichel Préville
Sep 17, 2004·Issues in Mental Health Nursing·Philippe VoyerCaroline Boivin
Jul 14, 2010·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Svetlana SkurtveitAage Tverdal
Sep 25, 2003·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Shelly L GrayAndrea Z LaCroix
Sep 25, 2007·General Hospital Psychiatry·Joan M CookJames C Coyne
Sep 22, 2007·Journal of Clinical Epidemiology·Roy StewartBetty Meyboom-De Jong
Nov 7, 2015·European Psychiatry : the Journal of the Association of European Psychiatrists·T A T KurkoJ Hietala
Dec 21, 2007·British Journal of Clinical Pharmacology·Hendrika J LuijendijkBruno H Ch Stricker
Dec 7, 2007·International Journal of Geriatric Psychiatry·Jur-Shan ChengYaw-Tang Shih
May 9, 2007·Pharmacoepidemiology and Drug Safety·Anne Margrethe HauskenAage Tverdal
Jan 12, 2011·British Journal of Clinical Pharmacology·Leonie MantheyFrans G Zitman
Dec 7, 2013·Perspectives in Psychiatric Care·You-Hong LiTian-Mei Si
Jun 10, 2010·Journal of Psychiatric and Mental Health Nursing·P VoyerM Préville
Feb 20, 2015·Pharmacoepidemiology and Drug Safety·Margit KriegbaumMerete Osler
Mar 26, 2013·Nordic Journal of Psychiatry·Trond NordfjærnRolf Gråwe
Jun 13, 2015·Néphrologie & thérapeutique·Mathieu CollombCarole Paillet
Mar 10, 2015·Aging & Mental Health·Guilhème PérodeauKieron O'Connor
Jan 15, 2010·Social Science & Medicine·Ingeborg HartzSvetlana Skurtveit
Jul 12, 2013·The International Journal of Neuropsychopharmacology·Ramit Ravona-Springer, Michael Davidson
Feb 8, 2011·The International Journal of Neuropsychopharmacology·Phern-Chern TorRoss J Baldessarini
Jun 12, 2014·Journal of Gerontological Social Work·Sarah L CanhamLinda Simoni-Wastila
Mar 6, 2003·Pharmacoepidemiology and Drug Safety·Rolf van HultenHubert G Leufkens
Jan 1, 2010·International Journal of Law and Psychiatry·Eric Lavigne, Renée Bourbonnais
Mar 1, 2003·European Journal of Clinical Pharmacology·Rolf van HultenHubert G Leufkens
Apr 5, 2017·International Journal of Mental Health Nursing·Elaine SangMin-Huey Chung
Sep 24, 2004·Pharmacoepidemiology and Drug Safety·Dustin D FrenchDavid M Angaran
Dec 13, 2005·Pharmacy World & Science : PWS·Anders Ekedahl, Gunnar Lindberg

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.